CareDx completed its acquisition of Naveris after all closing conditions were satisfied, marking the final step of the previously announced deal. While no financial terms were provided, the completed M&A transaction can support CareDx’s oncology diagnostics footprint and may influence the stock modestly.
CareDx completed its acquisition of Naveris after all closing conditions were satisfied, marking the final step of the previously announced deal. While no financial terms were provided, the completed M&A transaction can support CareDx’s oncology diagnostics footprint and may influence the stock modestly.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.10
Ticker Sentiment
